ELVN Enliven Therapeutics, Inc.
Price Chart
Executive Summary
Board member Lori Anne Kunkel filed a Form 144 notice of intent to sell 20,000 shares of Enliven Therapeutics (ELVN), with an estimated aggregate market value of $709,800. The sale is planned under a Rule 10b5-1 trading plan adopted on March 6, 2026, indicating the insider established the plan months before this filing and is not acting on recent material non-public information. Given the small relative size of the proposed sale (approximately 0.03% of the $2.2B market cap) and the pre-planned nature, this filing is routine and unlikely to materially impact the stock.
Actionable Insight
The Form 144 is a routine advance notice of a planned insider sale under a pre-existing 10b5-1 plan. No material impact expected. Monitor for actual execution on Form 4, but the small size and pre-planned nature suggest no negative signal. The stock's strong analyst consensus (94% bullish) and positive historical drift (+12.2% at T+20 on prior reports) support a neutral read-through.
Key Facts
- Board member Lori Anne Kunkel filed Form 144 to sell 20,000 shares of ELVN common stock.
- Estimated aggregate market value of the proposed sale is $709,800.
- Sale is to be executed under a Rule 10b5-1 trading plan adopted on March 6, 2026.
- Shares were acquired pre-IPO on March 12, 2020, as 'Pre-IPO Shares'.
- Proposed sale represents approximately 0.03% of ELVN's $2.2B market cap.
Financial Impact
Proposed sale of 20,000 shares worth approximately $709,800, representing a small fraction of the company's $2.2B market cap.
Risk Factors
- Insider sale could be perceived negatively by retail investors despite the 10b5-1 plan.
- If the company's stock price weakens ahead of the sale, the plan may still execute, adding modest sell pressure.
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001974158-26-000072 |
| Document: 0001974158-26-000072-index.html | 0001974158-26-000072 |
| Document: 0001974158-26-000072.txt | 0001974158-26-000072 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
today
|
424B5
| $46.12 awaiting T+20 | awaiting T+20 | — | $46.13 (−0.02%) |
|
Jun 11, 2026
1d ago
|
8-K
| $38.00 awaiting T+20 | awaiting T+20 | — | $46.13 (+21.39%) |
|
Jun 5, 2026
7d ago
|
144
| $35.44 awaiting T+20 | awaiting T+20 | — | $46.13 (+30.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access